Drug profile · INN
vorapaxar sulfate
ZONTIVITY
vorapaxar sulfate (ZONTIVITY) is a proteinase-activated receptor 1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — vorapaxar sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
vorapaxar sulfate (ZONTIVITY) is a proteinase-activated receptor 1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Proteinase-activated receptor 1 antagonist
Primary target: Proteinase-activated receptor 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is vorapaxar sulfate?
vorapaxar sulfate (ZONTIVITY) is a proteinase-activated receptor 1 antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vorapaxar sulfate?
ZONTIVITY is a marketed brand name for vorapaxar sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vorapaxar sulfate?
vorapaxar sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.